BPC-157 Systemic Effects: New Meta-Analysis Confirms Accelerated Tissue Repair Across Multiple Injury Models
A landmark meta-analysis of 47 preclinical studies confirms BPC-157's (Body Protection Compound 157) dose-dependent effects on tendon, muscle, and gut epithelium repair. Researchers at the Zagreb School of Medicine synthesized data showing significant upregulation of growth hormone receptor expression and VEGF signaling pathways, pointing toward Phase I human trial feasibility. The compound's oral and injectable bioavailability profiles were also compared for the first time in a systematic review.